Sonnet Biotherapeutics
$1.26
82
-$1.84-59.35% Tuesday 21:00
Statistics
Day High
3.23
Day Low
1.26
52W High
19.3
52W Low
1.08
Volume
8,637,536
Avg. Volume
957,723
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
16DecExpected
Expected EPS
-0.49
Actual EPS
-0.79
Financials
-39,142.11%Profit Margin
Unprofitable19,000Revenue
-7.44MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SONN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Allogene Therapeutics
ALLO
Mkt Cap275.13M
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
Fate Therapeutics
FATE
Mkt Cap155.7M
Gilead Sciences
GILD
Mkt Cap148.78B
Novartis
NVS
Mkt Cap237.61B
About
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.
Show more...
CEO
Mr. Raghu Rao
Employees
13
Country
US
ISIN
US83548R1059
Listings
0 Comments
Share your thoughts
FAQ
What is Sonnet Biotherapeutics stock price today?▼
The current price of SONN is $1.26 USD — it has decreased by -59.35% in the past 24 hours. Watch Sonnet Biotherapeutics stock price performance more closely on the chart.
What is Sonnet Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sonnet Biotherapeutics stocks are traded under the ticker SONN.
Is Sonnet Biotherapeutics stock price growing?▼
SONN stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Sonnet Biotherapeutics has showed a +0.8% increase.
What were Sonnet Biotherapeutics earnings last quarter?▼
SONN earnings for the last quarter are -0.79 USD per share, whereas the estimation was -0.49 USD resulting in a -61.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sonnet Biotherapeutics revenue for the last year?▼
Sonnet Biotherapeutics revenue for the last year amounts to 19,000 USD.
What is Sonnet Biotherapeutics net income for the last year?▼
SONN net income for the last year is -7.44M USD.
How many employees does Sonnet Biotherapeutics have?▼
As of April 04, 2026, the company has 13 employees.
In which sector is Sonnet Biotherapeutics located?▼
Sonnet Biotherapeutics operates in the Health Care sector.
When did Sonnet Biotherapeutics complete a stock split?▼
The last stock split for Sonnet Biotherapeutics was on September 30, 2024 with a ratio of 1:8.
Where is Sonnet Biotherapeutics headquartered?▼
Sonnet Biotherapeutics is headquartered in Princeton, US.